Literature DB >> 10798979

HIV-associated dementia.

E O Major, D Rausch, C Marra, D Clifford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10798979     DOI： 10.1126/science.288.5465.439d

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  18 in total

1.  Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients.

Authors:  Dianne Langford; Jennifer Marquie-Beck; Sergio de Almeida; Deborah Lazzaretto; Scott Letendre; Igor Grant; J Allen McCutchan; Eliezer Masliah; Ronald J Ellis
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

2.  MSM ameliorates HIV-1 Tat induced neuronal oxidative stress via rebalance of the glutathione cycle.

Authors:  Seol-Hee Kim; Adam J Smith; Jun Tan; R Douglas Shytle; Brian Giunta
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

3.  Better quality of life with neuropsychological improvement on HAART.

Authors:  Thomas D Parsons; Alyssa J Braaten; Colin D Hall; Kevin R Robertson
Journal:  Health Qual Life Outcomes       Date:  2006-02-24       Impact factor: 3.186

Review 4.  Experimental and potential future therapeutic approaches for HIV-1 associated dementia targeting receptors for chemokines, glutamate and erythropoietin.

Authors:  M Kaul; S A Lipton
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

5.  Circulating proviral HIV DNA and HIV-associated dementia.

Authors:  Bruce Shiramizu; Suzanne Gartner; Andrew Williams; Cecilia Shikuma; Silvia Ratto-Kim; Michael Watters; Joleen Aguon; Victor Valcour
Journal:  AIDS       Date:  2005-01-03       Impact factor: 4.177

6.  Callosal degradation in HIV-1 infection predicts hierarchical perception: a DTI study.

Authors:  Eva M Müller-Oehring; Tilman Schulte; Margaret J Rosenbloom; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Neuropsychologia       Date:  2009-12-16       Impact factor: 3.139

7.  Neuroprotective activities of CEP-1347 in models of neuroAIDS.

Authors:  Dawn Eggert; Prasanta K Dash; Santhi Gorantla; Huanyu Dou; Giovanni Schifitto; Sanjay B Maggirwar; Stephen Dewhurst; Larisa Poluektova; Harris A Gelbard; Howard E Gendelman
Journal:  J Immunol       Date:  2009-12-04       Impact factor: 5.422

8.  Amount of HIV DNA in peripheral blood mononuclear cells is proportional to the severity of HIV-1-associated neurocognitive disorders.

Authors:  Bruce Shiramizu; Andrew E Williams; Cecilia Shikuma; Victor Valcour
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

9.  The glial response to CNS HIV infection includes p53 activation and increased expression of p53 target genes.

Authors:  Suman Jayadev; Bomy Yun; Huy Nguyen; Hideaki Yokoo; Richard S Morrison; Gwenn A Garden
Journal:  J Neuroimmune Pharmacol       Date:  2007-10-20       Impact factor: 4.147

10.  A rat model of human immunodeficiency virus 1 encephalopathy using envelope glycoprotein gp120 expression delivered by SV40 vectors.

Authors:  Jean-Pierre Louboutin; Lokesh Agrawal; Beverly A S Reyes; Elisabeth J Van Bockstaele; David S Strayer
Journal:  J Neuropathol Exp Neurol       Date:  2009-05       Impact factor: 3.685
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.